NXSTAGE MEDICAL INC's ticker is NXTM and the CUSIP is 67072V103. A total of 149 filers reported holding NXSTAGE MEDICAL INC in Q2 2016. The put-call ratio across all filers is 0.08 and the average weighting 0.4%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q2 2017 | $5,362,000 | +29.9% | 213,901 | +39.0% | 0.77% | +17.7% |
Q1 2017 | $4,129,000 | -0.9% | 153,901 | -3.1% | 0.65% | -18.0% |
Q4 2016 | $4,165,000 | -99.9% | 158,901 | +9.4% | 0.80% | +38.3% |
Q3 2016 | $3,631,047,000 | +115171.3% | 145,300 | 0.0% | 0.58% | +3.2% |
Q2 2016 | $3,150,000 | – | 145,300 | – | 0.56% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Burren Capital Advisors Ltd | 29,200 | $806,000 | 9.11% |
ALPINE ASSOCIATES MANAGEMENT INC. | 7,982,916 | $220,326,000 | 3.72% |
DAFNA Capital Management LLC | 216,119 | $5,965,000 | 3.70% |
Versor Investments LP | 406,502 | $11,219,000 | 3.67% |
Trellus Management Company, LLC | 80,000 | $2,204,000 | 3.02% |
Pennant Capital Management, LLC | 1,622,066 | $44,769,000 | 2.75% |
KOPP INVESTMENT ADVISORS LLC | 106,586 | $2,942,000 | 2.70% |
DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 1,579,285 | $43,588,000 | 1.96% |
Cheyne Capital Management (UK) LLP | 190,000 | $5,243,000 | 1.89% |
First Light Asset Management, LLC | 183,592 | $5,067,000 | 1.60% |